HER2 drives lung fibrosis by activating a metastatic cancer signature in invasive lung fibroblasts is a research paper published in The Journal of Experimental Medicine (2022). On theSindex it has a DataRank of 0. It has been cited 33 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: R01 AI052201
National Institutes of Health
Grant: R01 HL060539
National Institutes of Health
Grant: P01 HL108793
National Institutes of Health
Grant: R01 HL122068
National Institutes of Health
Grant: R01 HL123899
NHLBI NIH HHS
Grant: R35 HL150829
National Institutes of Health
Grant: 5R01HL123899-04
Innate DNA sensing in rapidly progressing IPF
National Institutes of Health
Grant: 5R01HL122068-04
Targeting beta-arrestins in Pulmonary Fibrosis
National Institutes of Health
Grant: 5R01HL060539-18
Matrix Regulation of Pulmonary Fibrosis
National Institutes of Health
Grant: 5P01HL108793-10
Epithelial-Mesenchymal Interactions in Pulmonary Fibrosis and Chronic Allograft Dysfunction (CLAD)
National Institutes of Health
Grant: 7R01AI052201-11
Innate Immune Mechanisms in Non-infectious Lung Inflammation
FWCI
3.95
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals